Related Experiment Videos
Treating hypertension in the elderly
1Health Sciences Centre, Lund University, Dalby, Sweden.
Insights
Hypertension affects 50% of older adults. While blood pressure medication benefits many elderly individuals, its effectiveness and safety in the very oldest patients (80+ years) require further investigation due to age-related cardiovascular changes.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Hypertension is highly prevalent in the elderly (approx. 50%).
- Increased cardiovascular disease (CVD) risk is noted in hypertensive individuals aged 60-79, but this risk appears reduced in those 80+.
- Age-related cardiovascular changes complicate antihypertensive treatment in older adults.
Purpose of the Study:
- To evaluate the efficacy and safety of antihypertensive drug treatment in elderly patients, particularly the oldest old (80+ years).
- To address the lack of data on treating isolated systolic hypertension in the elderly.
Main Methods:
- Review of existing literature on hypertension management in the elderly.
- Analysis of cardiovascular risk factors and treatment outcomes in different age subgroups of the elderly.
- Consideration of physiological changes associated with aging impacting drug efficacy and safety.
Main Results:
- Antihypertensive treatment is generally beneficial for most elderly patients.
- The benefit of antihypertensive treatment in patients aged 80 years and older is less clear.
- Specific challenges exist in treating hypertension in the elderly due to impaired blood pressure homeostasis and altered cardiovascular structure/function.
Conclusions:
- Antihypertensive drug treatment requires careful consideration and cautious application in the elderly due to age-related physiological changes.
- Further research is needed to clarify the benefits and risks of antihypertensive therapy in the oldest elderly population (80+ years) and those with isolated systolic hypertension.
Abstract:
Hypertension is a common problem in the elderly, with a prevalence of about 50%. The risk of cardiovascular disease and death is increased in hypertensive patients aged 60-79 years, whereas this increased risk seems to be diminished or even non-existent in those aged > or = 80 years. Antihypertensive drug treatment has been shown to be beneficial for most elderly patients but whether this is also true for the oldest patients is less clear. Treatment is more difficult in the elderly than in the middle aged or young because of the structural and functional alterations of the cardiovascular system associated with ageing (in particular the impairment of BP homeostasis), which contraindicate some drugs and impose a cautious use of the remaining ones. Isolated systolic hypertension increases the cardiovascular risk but we lack data on the efficacy of treatment in this group.